ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag kidney cancer culture

The Little Cell That Could
Megan Scudellari | Jul 1, 2012 | 7 min read
Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.
An illustration of flowers in the shape of the female reproductive tract
Uterus Transplants Hit the Clinic
Jef Akst | Aug 1, 2021 | 10+ min read
With human research trials resulting in dozens of successful deliveries in the US and abroad, doctors move toward offering the surgery clinically, while working to learn all they can about uterine and transplant biology from the still-rare procedure.
Researchers Engineer Epigenome Editors to Study How Gene Expression Affects Disease
Ashley Yeager | Jan 1, 2019 | 7 min read
Using CRISPR and other tools, scientists are modifying DNA methylation, histone marks, and other modifiers of gene expression to understand how they affect health and disease.
Advances in the functional characterization of newly discovered microproteins hint at their diverse roles  in health and disease
The Dark Matter of the Human Proteome
Annie Rathore | Apr 1, 2019 | 10 min read
Advances in the functional characterization of newly discovered microproteins hint at diverse roles in health and disease.
With CRISPR, Modeling Disease in Mini Organs
Tanya Lewis | May 6, 2016 | 3 min read
Organoids grown from genetically edited stem cells are giving scientists a new tool to screen drugs and test treatments.
Top 10 Innovations 2016
The Scientist | Dec 1, 2016 | 10+ min read
This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.
The Rise of Free, Global Gene Expression Data Sets
Jim Kling | Apr 1, 2002 | 5 min read
See related Techlink, "The Data Analysis Grand Prix". For this article, Jim Kling interviewed Patrick O. Brown, Howard Hughes Medical Institute investigator and professor in the department of biochemistry, Stanford University Medical School in Stanford, Calif., and John N. Weinstein, senior investigator at the National Cancer Institute and head of the genomics and bioinformatics group, in Bethesda, Md. Data from the Web of Science show that Hot Papers are cited 50 to 100 times more often than t
Antibody Alternatives
Paul Ko Ferrigno and Jane McLeod | Feb 1, 2016 | 10+ min read
Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.
Rethinking Lymphatic Development
Amanda B. Keener | Aug 1, 2015 | 9 min read
Four studies identify alternative origins for cells of the developing lymphatic system, challenging the long-standing view that they all come from veins.
Integrin Signaling at a Crossroads
Megan Stephan(mstephan@the-scientist.com) | Sep 11, 2005 | 6 min read
Integrins serve as the cell's conduit to the outside world, sensing the external environment and passing on instructions: differentiate or not, adhere or move on, live or die.

Run a Search

ADVERTISEMENT